(June 30, 2020 / JNS) Israel began conducting mass serological testing on Monday to detect COVID-19 antibodies, amid rising concern over a “second wave” of infections.
Around 80,000 tests will be taken across the country, according to a report by Israel’s Channel 12.
Tuesday saw the highest daily rise in COVID-19 cases in the country since April 2. Since Monday at midnight, 714 new cases were confirmed, the third-highest daily tally since the onset of the pandemic in Israel.
It is estimated that the number of those exposed to the virus is 10 times the number actually diagnosed as carriers (24,441), indicating a far greater infection rate than previously thought.
The serological test is not used to diagnose whether or not a person has the disease, but can detect antibodies to it that appear about 21 days after a person has been infected. Those in whom antibodies are found are considered to have been coronavirus carriers, but it is still unclear whether such a person can become infected again or not.
Israel’s Ministry of Health has instructed that those found to have antibodies but who were not previously known to have had the disease will be sent for coronavirus testing.
There may also be people infected with the virus but who do not develop antibodies. However, their numbers in relation to all patients are likely to be low. The sensitivity of the antibody detection test is 95 percent, according to the report.
“This is a very, very important survey,” emphasized Sigal Dadon Levy, head of the Sharon district of Israel’s Maccabi Health Services. “It basically allows us to get information about the true extent of the infection. The purpose of the test is to see if a person has developed antibodies as a result of being exposed to corona.”
Support Jewish Journalism
with 2020 Vision
One of the most intriguing stories of the sudden Coronavirus crisis is the role of the internet. With individuals forced into home quarantine, most are turning further online for information, education and social interaction.
JNS's influence and readership are growing exponentially, and our positioning sets us apart. Most Jewish media are advocating increasingly biased progressive political and social agendas. JNS is providing more and more readers with a welcome alternative and an ideological home.
During this crisis, JNS continues working overtime. We are being relied upon to tell the story of this crisis as it affects Israel and the global Jewish community, and explain the extraordinary political developments taking place in parallel.
Our ability to thrive in 2020 and beyond depends on the generosity of committed readers and supporters. Monthly donations in particular go a long way in helping us sustain our operations. We greatly appreciate any contributions you can make during these challenging times. We thank you for your ongoing support and wish you blessings for good health and peace of mind.